ARDX vs PODD · rev $215.3M vs P/E 34, rev $1.56B
Ardelyx Inc (ARDX) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
Ardelyx Inc (ARDX) is a biotechnology company listed on US.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported ARDX revenue for 2026-06-30 was $215.3M. Net income was -$54.3M. ARDX currently screens at market cap $1.37B.
Latest reported PODD revenue for 2026-06-30 was $1.56B. Net income was $186.1M. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
ARDX currently screens at market cap $1.37B. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the ARDX and PODD stock pages for the full models.
Not investment advice.